Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing human menopausal gonadotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human menopausal gonadotropin |
Inferred relationship |
Some |
1 |
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Product containing human menopausal gonadotropin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 75units(FSH) powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 150units(FSH) injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 75iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotrophins 150iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|
Human menopausal gonadotropin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human menopausal gonadotropin |
Inferred relationship |
Some |
1 |
Menotropin is a term that originally referred to early human menopausal gonadotropin (hMG) preparations containing a 1:1 ratio of follicle-stimulating hormone (FSH) to luteinizing hormone (LH). However, the term is also used broadly to describe any hMG product. Modern hMG formulations vary in their FSH/LH ratios, allowing for more individualized treatment approaches. |
Is a |
True |
Human menopausal gonadotropin |
Inferred relationship |
Some |
|